The president of the Cannabinoid Industry Association is joining an Atlanta-based hemp company, Verde Leaf, to lead testing and product development for a new subsidiary making CBD products.
Priscilla Agoncillo will be board chairwoman and president of Medadex Pharma, a new subsidiary of the privately-held hemp grower and processor.
She will oversee product development and efficacy testing for Medadex, with plans to develop pharmaceutical-grade CBD treatments approved by the U.S. Food and Drug Administration.
Agoncillo is a longtime cannabis entrepreneur and activist in California. She was campaign field director for that state’s unsuccessful 2010 campaign to legalize recreational marijuana.